why choose us

Clinical Trials Search

Showing 15,460 of 132,656 result(s)
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Status: Completed

Condition: Renal Cell Carcinoma

Interventions: 100 mg; 4mL on Day 1 of each 3- or 6- week cycle (one 3 wk cycle; up to eight 6 wk cycles)

Date: 2023-01-30

Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence

Status: Completed

Condition: Fecal Incontinence

Interventions:

Patients will be given home biofeedback device to take home and practice biofeedback exercises at least twice a day for six weeks of therapy.

Date: 2023-01-30

Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer

Status: Completed

Condition: Breast Cancer

Interventions: o In Phase A (~32 weeks), AT will consist of supervised walking delivered up to 7 days per week using an adaptive dosing schedule that starts at 90 mi

Date: 2023-01-30

Blueberries, Inflammation, Motivation, and Physical Activity

Status: Completed

Condition: Depressive Symptoms

Interventions: Participants will be asked to consume 48 grams of freeze-dried blueberry powder (~ equivalent to 2 cups of fresh blueberries) daily for 12 weeks.

Date: 2023-01-30

REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant

Status: Completed

Condition: Delirium in Old Age

Interventions: Administer Suvorexant versus placebo every evening for Post-Operative Day (POD) 0,1, &2

Date: 2023-01-30

Minimally Invasive Esophagectomy Pain Control Trial

Status: Completed

Condition: Postoperative Pain, Acute

Interventions: The pain service and thoracic surgery attending physician will assess if the patient's pain is not well-controlled using the pain modality they a

Date: 2023-01-30

Randomized Controlled Trial of a Gender-transformative School-based Sexual Health Intervention

Status: NOT_YET_RECRUITING

Condition: Sexuality

Interventions: ENFOCATE is a comprehensive program of sexual education for adolescents.
Its design follows the guidelines of the Intervention Mapping Approach a

Date: 2023-01-30

Evaluating Outcomes in Cardiac Surgery Patients Who Receive Sugammadex vs. Placebo

Status: Completed

Condition: Surgery

Interventions: Fifteen minutes after ICU arrival, subjects will be administered sugammadex (2 mg;kg assuming a twitch count of 2-4 of 4 or 4mg;kg assuming

Date: 2023-01-30

CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study

Status: Completed

Condition: Tricuspid Valve Disease

Interventions: Tricuspid valve replacement with the Cor TRICUSPID ECM Valve for the surgical management of tricuspid valve disease or dysfunction.

Date: 2023-01-30

Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors

Status: Completed

Condition: Metastatic Malignant Solid Neoplasm

Interventions: Undergo collection of blood samples

Date: 2023-01-30